Top 34 Artiva Biotherapeutics investors
The most complete profiles first. Showing 34 of 34.
Andy SchwabVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 57 more
Verified email available
Brian DanielsVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Deborah PalestrantVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Jason RuthVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Joshua KennedyVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Verified email available
Lou TartagliaVerified
Venture Capital, Founder, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Verified email available
Rebecca ChenVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Richard GasterVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Verified email available
Stephanie A. SirotaVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsEnterprise SoftwareInvestment ManagementPortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Verified email available
David PezeshkiVerified
Private Equity Firm · United States
Health CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Verified email available
Elliot EhrichVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Jonathan WeissmanVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Oleg NodelmanVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Paul StoneVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Sarah MarriottVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Scott PlatshonVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Aaron Royston, M.D.
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, HistoWiz and 35 more
Contact details available
Jamil M. Beg
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Jaume Pons
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Contact details available
John Diekman
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
Mason Freeman
Venture Capital, Investor · United States
SeedHealth CareHospitalsGeneticsLife SciencePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Mira Chaurushiya
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsAlternative MedicineAndroidPortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Naveen Yalamanchi
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Piratip Pratumsuwan
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more
Contact details available
Roderick Wong
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more
Contact details available
Sabera Loughran
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Scott Rocklage
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
Tony Nguyen
Hedge Fund, Venture Capital, Investor · United States
Series BAdvertisingHealth CareGeneticsInvestment ManagementPortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Yvonne Yamanaka
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Contact details available
Caroline Stout
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Contact details available
Joseph Victor
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Peter Kim
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Paul KimVerified
Venture Capital · South Korea
Health CareWomen FoundedLife ScienceManufacturingPortfolio: WindMIL Therapeutics, Cognate BioServices, Artiva Biotherapeutics, SillaJen
Verified email available
Roger Kang
Venture Capital, Private Equity Firm
Health CareWomen FoundedLife ScienceManufacturingPortfolio: WindMIL Therapeutics, Cognate BioServices, Artiva Biotherapeutics, SillaJen
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Artiva Biotherapeutics investors are on Angel Roster?
Angel Roster lists 34 Artiva Biotherapeutics investors. 15 of them (44%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (33), Private Equity Firms (17) and Hedge Funds (7). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Artiva Biotherapeutics investors invest in?
Among those that list a stage, the most common are Seed (11) and Series B (11).
Where are Artiva Biotherapeutics investors based?
Most are based in the United States (32) and South Korea (1).
Which companies have Artiva Biotherapeutics investors backed?
The most-backed portfolio companies among them are Cidara Therapeutics (21), Impel NeuroPharma (21), Neurogastrx (21), Akouos (20) and scPharmaceuticals (16).
How do I contact Artiva Biotherapeutics investors?
Create a free Angel Roster account to search and filter all 34, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.